New Report Profiles the Gastroesophageal Reflux Disease Drug Pipeline
Posted on: Wednesday, 12 September 2007, 09:02 CDT
Research and Markets (http://www.researchandmarkets.com/reports/c68199) has announced the addition of Digestive System - Gastroesophageal Reflux Disease Drug Pipeline Report to their offering.
"Digestive System - Gastroesophageal Reflux Disease Drug Pipeline Report" contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of gastroesophageal reflux disease drugs by company and by stage as well as a summary of the latest news and developments in this area.
Scope of the report:
Each Therapy Area Pipeline Report provides the user with real detail on drug pipelines, by company and by stage, for each specific therapy area. The latest news, by company, also ensures that each report is fresh and up-to-date.
In addition to new developments and disease specific pipeline projects, each report also contains extensive information in tabular format on a company's full product pipeline and products by phase of development with regard to the therapy area.
Full pipeline details, by stage, are provided and include detailed product descriptions, information on partnering activity plus clinical trial intelligence. Each Therapy Area Pipeline Report also provides detail on the top 20 companies with products in the early stage of development and the top 20 companies with products in the late stage of development. Finally, each report also provides a comparison with other major indications in the disease hub based on Marketed Products vs. Pipeline Products.
Key benefits
- Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline for specific therapy areas.
- Keep track of your competitors and partners by better understanding their product pipeline.
- Monitor a company's research effectiveness by determining pipeline depth and number of products in development by clinical phase for specific disease areas.
- Maintain a critical competitive advantage.
RECENT HIGHLIGHTS AND CHANGES
--Recent Highlights and Changes
UPCOMING PATENT EXPIRES BY THERAPY AREA
Gastroesophageal Reflux Disease Pipeline Overview
--% of Projects (By Phase of Development)
--No. of Projects by Phase of Development
--Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
--Company Overview - Pipeline Projects
--Legend
--Top 20 companies in late stage Gastroesophageal Reflux Disease Projects
--Top 20 companies in early stage Gastroesophageal Reflux Disease Projects
Full Pipeline View
--Pre Clinical Pipeline View
--Phase II Pipeline View
--Pending Approval Pipeline View
--Approved Pipeline View
For more information visit http://www.researchandmarkets.com/reports/c68199
Source: Life Science Analytics
Source: Business Wire
Related Articles
- Yamana Gold provides development and near development stage projects update
- USRA Honored by NASA for Design, Implementation of Critical Program/Project Management Development Program
- ONEOK Partners Announces Completion of Guardian Pipeline Expansion and Extension Project
- Record Number of Innovative New Medicines for Heart Disease and Stroke Now in Development
- NxStage(R) Achieves Milestone With 3,000 End-Stage Renal Disease Patients Receiving Daily Home Hemodialysis Therapy
- PSTS China to Commence Production Expansion Project
- Amorcyte Secures Production Capacity for Lead Cell Therapy Product; Progenitor Cell Therapy LLC is Retained to Develop and Manufacture AMR-001
- BigLever Software Helps Bridge the Communication Gap Between Product Marketing and Software Development to Streamline Product Line Evolution
- Resolution Health Inc. (RHI) Expands Management Team; Healthcare Veteran Alan Wright, MD, MPH, Named Vice President of Product Strategy and Business Development
- NanoOpto Announces Addition of Maria Light As Director of Product Management and Business Development; Expansion of Executive Team Supports Product Commercialization and Market Expansion
 |
 |
User Comments (0)
RSS Feeds